U.S. patent number D626,216 [Application Number D/274,154] was granted by the patent office on 2010-10-26 for medical injector. This patent grant is currently assigned to Sanofi-Aventis Deutschland GmbH. Invention is credited to Daniel Paul Charles Tyce.
United States Patent | D626,216 |
Tyce | October 26, 2010 |
Inventors: | Tyce; Daniel Paul Charles (Warwickshire, GB) |
---|---|
Assignee: | Sanofi-Aventis Deutschland GmbH
(Frankfurt, DE) |
Appl. No.: | D/274,154 |
Filed: | March 30, 2007 |
Oct 30, 2006 [EM] | 000620851 | |||
Current U.S. Class: | D24/114 |
Current International Class: | 2402 |
Field of Search: | ;D19/35,36,41,43,44,45,46,47,48,49,50,51,54,55,56,57 ;D24/108,112,113,114,130,133,138,146,147 ;604/187,188,189,197,198,207,208,227,229,232 ;606/181,182,185 |
2398544 | April 1946 | Lockhart |
3045593 | July 1962 | Petterson |
3254836 | June 1966 | Corpian |
4637403 | January 1987 | Garcia et al. |
D289424 | April 1987 | Huang |
4973318 | November 1990 | Holm et al. |
D324070 | February 1992 | Suzuki |
5334144 | August 1994 | Alchas et al. |
5569214 | October 1996 | Chanoch |
D390872 | February 1998 | Sunaga |
D414201 | September 1999 | Larson et al. |
D426299 | June 2000 | Bydlon et al. |
D426572 | June 2000 | Salemme et al. |
6110149 | August 2000 | Klitgaard et al. |
D451138 | November 2001 | Rosenbaum |
D462760 | September 2002 | Ahlgrim et al. |
6454746 | September 2002 | Bydlon et al. |
D479602 | September 2003 | Bainton |
D479747 | September 2003 | Bainton |
D479748 | September 2003 | Tyce |
D483067 | December 2003 | Takanashi |
D492027 | June 2004 | Tyce et al. |
D492405 | June 2004 | Bainton |
D501253 | January 2005 | Bainton |
D502739 | March 2005 | Shova et al. |
D503797 | April 2005 | Tyce |
D505490 | May 2005 | Tyce |
6932794 | August 2005 | Giambattista et al. |
7018364 | March 2006 | Giambattista et al. |
D540465 | April 2007 | Bainton |
D567939 | April 2008 | Mattigka |
7534222 | May 2009 | Sugita et al. |
D599009 | August 2009 | Tyce |
D599010 | August 2009 | Tyce |
D600794 | September 2009 | Tyce |
D600795 | September 2009 | Tyce |
7621891 | November 2009 | Wyrick |
2004/0106895 | June 2004 | Slate et al. |
2004/0236284 | November 2004 | Hoste et al. |
2005/0187523 | August 2005 | Giambattista et al. |
2005/0234492 | October 2005 | Tsai et al. |
2005/0251103 | November 2005 | Steffen et al. |
2006/0155246 | July 2006 | Higuchi et al. |
2006/0229570 | October 2006 | Lovell et al. |
2007/0123829 | May 2007 | Atterbury et al. |
2007/0129687 | June 2007 | Marshall et al. |
2009/0076458 | March 2009 | Nielsen et al. |
SoloStar disposable pen injector by DCA Design International for Sanofi Aventis GmbH, as shown on www.effectivedesign.org.uk, dated Oct. 22, 2009 (3 pages). cited by examiner . DCA brochure for SoloStar disposable pen injector for insulin, as found on www.effectivedesign.org.uk, as indicated at arrow on Item "U" above, dated Jun. 2, 2009 (10 pages). Reference to date of product launch (2007) on p. 2, last paragraph. cited by examiner . Article on www.diabeteshealth.com about FDA approval of Lantus SoloStar disposable insulin pen, with a picture of the product, dated May 4, 2007 (5 pages). cited by examiner. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.